Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL153P, or RNA, 7SL, cytoplasmic 153, pseudogene, is a non-coding, processed pseudogene in the human genome derived from the 7SL RNA gene, which encodes the RNA component of the signal recognition particle (SRP)[1][3][6][8]. This pseudogene does not produce functional RNA or protein, as it is typically truncated and contains mutations preventing proper expression[1][3][9]. There are hundreds of 7SL RNA pseudogenes dispersed in the human genome, of which RN7SL153P is one example, generated by reverse transcription and integration of 7SL RNA into DNA[1][3][9]. Unlike the functional 7SL RNA gene, which has roles in protein targeting to membranes as part of the SRP complex[5][7], RN7SL153P has no known biological function, clinical relevance, or disease associations, nor is it considered a therapeutic target[6][8]. As a non-functional pseudogene, it possesses no documented biological activity, disease association, or relevance to drug interactions, and thus, information about this locus should be considered incorrect for target-based therapeutic or biomarker research[6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 153, pseudogene (RN7SL153P).